Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillationJoseph Biskupiak, Sameer R Ghate, Tianze Jiao, et al.Journal of Medical Economics|February 22, 2013
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcomaKarina Raimundo, Joseph Biskupiak, Michael Goodman, et al.Oncology Research and Treatment|July 27, 2021
Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect ComparisonAditi Kharat, Madeline Brendle, Anindit Chhibber, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 30, 2024
An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19Daniel C Malone, Joseph Biskupiak, Diana Brixner, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
Antiplatelet medication management in patients hospitalized with ischemic strokeNancy A Nickman, Joseph Biskupiak, Freddy Creekmore, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Payer perceptions on the use of economic models in oncology decision makingJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of Managed Care & Specialty Pharmacy|July 27, 2019
Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast CancerJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of Managed Care Pharmacy : JMCP|November 5, 2011
All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillationSameer R Ghate, Joseph Biskupiak, Xiangyang Ye, et al.The American Journal of Emergency Medicine|December 18, 2020
Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital systemTheodoros V Giannouchos, Joseph Biskupiak, Michael J Moss, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 10, 2025
The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO studyDaniel C Malone, Roger Seheult, Diana Brixner, et al.Pageof 5